Interferons-α and -γ in clinical veterinary practice in the prevention and treatment of infectious diseases in cattle and pigs (review)

Author:

Shabunin S. V.1ORCID,Vostroilova G. A.1ORCID,Grigoryeva N. A.1ORCID,Zhukov M. S.1ORCID,Gritsyuk V. A.1ORCID

Affiliation:

1. All-Russian Veterinary Research Institute of Pathology, Pharmacology and Therapy

Abstract

The review article analyzes the existing world experience in the use of interferons IFN-α and -γ as well as drugs based on them in clinical veterinary practice in cattle and pigs. The selection of literary sources was carried out on the basis of their relevance and the depth of the research (search retrospectiveness is 30 years). It has been established that IFNs are widely used in the prevention and treatment of both infectious and non-infectious diseases, which can be divided into 3 groups: viral infections, oncological diseases, bacterial and aseptic diseases. The use of IFNs is due to their antiviral activity and immunoregulatory effect. Thus, IFN-α exhibits antiviral activity and is the first line of nonspecific immune defense, an inducer of IFN-γ synthesis and the main coordinator of the body's successful response to a viral infection. At the same time, IFN-γ provides immunoregulatory, anti-inflammatory and mediated antibacterial action by stimulating the production of macrophages and participating in the differentiation of lymphocytes. Clinical efficacy is expressed in a decrease or cessation of the infectious process, a decrease in leukocytosis and neutrophilia, relief of acidotic syndrome, an increase in the body weight of animals and an improvement in the general clinical condition. Currently, IFN therapy is one of the most promising and constantly expanding areas of immunopharmacology and treatment of common respiratory, gastrointestinal, obstetric-gynecological diseases in farm animals.

Publisher

FARC of the North-East named N.V. Rudnitskogo

Reference90 articles.

1. Chevaliez S., Pawlotsky J. M. Interferons and their use in persistent viral infections. Handb Exp Pharmacol. 2009;189:203-241. DOI: https://doi.org/10.1007/978-3-540-79086-0_8

2. George P. M., Badiger R., Alazawi W., Foster G. R., Mitchell J. A. Pharmacology and therapeutic potential of interferons. Pharmacol Ther. 2012;135(1):44-53. DOI: https://doi.org/10.1016/j.pharmthera.2012.03.006

3. Denisov L. A., Sholokhov I. V. Otkrytie interferona i ego klinicheskoe primenenie. [Interferon discovery and its clinical experience]. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious diseases. News, Opinions, Training. 2017;(1):23-31. (In Russ.). URL: https://cyberleninka.ru/article/n/otkrytie-interferona-i-ego-klinicheskoe-primenenie

4. Valiev T. T. Klinicheskoe primenenie interferonov: sovremennyy vzglyad na voprosy effektivnosti i bezopasnosti. Obzor literatury. [Interferon clinical use: modern view on efficacy and safety. Literature review]. Pediatriya. Consilium Medicum = Pediatrics. Consilium Medicum. 2020;(3):95-104. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=44155087

5. Vasilevsky I. V., Lavrienko A. V. Kliniko-farmakologicheskoe obosnovanie primeneniya interferonov v klinicheskoy praktike. [Clinico-pharmacological rationale for using interferons in clinical practice]. Zdravookhranenie = Healthcare. 2016;(7):51-63. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=28825240

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3